TABLE 3.
Factors associated with hospitalization due to COVID-19 (n = 622).
| Variable | Univariate analysis | Cox regression | ||||
|---|---|---|---|---|---|---|
| Odds ratio (OR) | OR 95% CI | p-value | Hazard ratio (HR) | HR 95% CI | p-value | |
| Female | 0.64 | 0.26–1.51 | 0.3177 | 0.63 | 0.25–1.54 | 0.3125 |
| Age | 1.00 | 0.97–1.03 | 0.7691 | |||
| Vaccine ≥3 doses | 0.32 | 0.13–0.75 | 0.0085 | 0.37 | 0.15–0.90 | 0.0269 |
| Transplant duration | 1.00 | 1.00–1.00 | 0.9337 | |||
| Creatinine level | 1.44 | 1.10–1.82 | 0.0034 | 1.23 | 0.91–1.56 | 0.1247 |
| Tacrolimus | 0.92 | 0.70–1.15 | 0.4987 | 0.89 | 0.67–1.13 | 0.3642 |
| mTOR inhibitor use | 0.47 | 0.19–1.10 | 0.0832 | 0.46 | 0.18–1.20 | 0.1154 |
| MMF | 1.19 | 0.53–2.73 | 0.6703 | |||
| Hypertension | 2.93 | 1.08–10.24 | 0.0545 | 3.24 | 1.07–13.98 | 0.0632 |
| Diabetes | 1.05 | 0.34–2.70 | 0.9323 | |||
CI, confidence interval; MMF, mycophenolate mofetil.